171 related articles for article (PubMed ID: 25899400)
21. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
[TBL] [Abstract][Full Text] [Related]
22. Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010.
Youlden DR; Soyer HP; Youl PH; Fritschi L; Baade PD
JAMA Dermatol; 2014 Aug; 150(8):864-72. PubMed ID: 24943712
[TBL] [Abstract][Full Text] [Related]
23. Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey.
Fondain M; Dereure O; Uhry Z; Guizard AV; Woronoff AS; Colonna M; Molinie F; Bara S; Velten M; Marrer E; Grosclaude P; Lapôtre-Ledoux B; Tretarre B; Guillot B
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1292-1296. PubMed ID: 29341266
[TBL] [Abstract][Full Text] [Related]
24. Incidence of Merkel cell carcinoma in renal transplant recipients.
Koljonen V; Kukko H; Tukiainen E; Böhling T; Sankila R; Pukkala E; Sihto H; Joensuu H; Kyllönen L; Mäkisalo H
Nephrol Dial Transplant; 2009 Oct; 24(10):3231-5. PubMed ID: 19586970
[TBL] [Abstract][Full Text] [Related]
25. Merkel cell carcinoma and melanoma: etiological similarities and differences.
Miller RW; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):153-8. PubMed ID: 10067813
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France.
Kieny A; Cribier B; Meyer N; Velten M; Jégu J; Lipsker D
Int J Cancer; 2019 Feb; 144(4):741-745. PubMed ID: 30194728
[TBL] [Abstract][Full Text] [Related]
27. Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study.
Pedersen SA; Johannesdottir Schmidt SA; Hölmich LR; Friis S; Pottegård A; Gaist D
J Am Acad Dermatol; 2019 Feb; 80(2):460-465.e9. PubMed ID: 29913261
[TBL] [Abstract][Full Text] [Related]
28. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
29. Trends in the incidence of Merkel cell carcinoma in Victoria, Australia, between 1986 and 2016.
Garbutcheon-Singh KB; Curchin DJ; McCormack CJ; Smith SD
Australas J Dermatol; 2020 Feb; 61(1):e34-e38. PubMed ID: 32040877
[TBL] [Abstract][Full Text] [Related]
30. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden.
Lorenzo Bermejo J; Pukkala E; Johannesen TB; Sundquist J; Hemminki K
Br J Haematol; 2014 Mar; 164(5):675-83. PubMed ID: 24528128
[TBL] [Abstract][Full Text] [Related]
31. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
Goggins WB; Finkelstein DM; Tsao H
Cancer; 2001 Feb; 91(4):874-80. PubMed ID: 11241258
[TBL] [Abstract][Full Text] [Related]
32. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
33. Treatment and survival of Merkel cell carcinoma since 1993: A population-based cohort study in The Netherlands.
Uitentuis SE; Louwman MWJ; van Akkooi ACJ; Bekkenk MW
J Am Acad Dermatol; 2019 Oct; 81(4):977-983. PubMed ID: 30703452
[TBL] [Abstract][Full Text] [Related]
34. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
[TBL] [Abstract][Full Text] [Related]
35. Rising incidence of Merkel cell carcinoma.
Lyhne D; Lock-Andersen J; Dahlstrøm K; Drzewiecki KT; Balslev E; Muhic A; Krarup-Hansen A
J Plast Surg Hand Surg; 2011 Dec; 45(6):274-80. PubMed ID: 22250719
[TBL] [Abstract][Full Text] [Related]
36. Trends in the incidence and morbidity of Merkel cell carcinoma in Brazil.
de Melo AC; Santos Thuler LC
Future Oncol; 2021 Aug; 17(22):2857-2865. PubMed ID: 33960199
[TBL] [Abstract][Full Text] [Related]
37. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007.
Reichgelt BA; Visser O
Eur J Cancer; 2011 Mar; 47(4):579-85. PubMed ID: 21144740
[TBL] [Abstract][Full Text] [Related]
39. Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries.
Fallah M; Kharazmi E; Pukkala E; Tretli S; Olsen JH; Tryggvadottir L; Sundquist K; Hemminki K
Leukemia; 2016 Feb; 30(2):373-8. PubMed ID: 26442613
[TBL] [Abstract][Full Text] [Related]
40. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
Moser EC; Noordijk EM; van Leeuwen FE; Baars JW; Thomas J; Carde P; Meerwaldt JH; van Glabbeke M; Kluin-Nelemans HC
Haematologica; 2006 Nov; 91(11):1481-8. PubMed ID: 17043014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
